Related Experiment Video

Updated: Jun 10, 2025

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.7K

Non-coding RNA and drug resistance in head and neck cancer

Yulong Zhang1,2, Yingming Peng1,2, Bingqin Lin1,3,2

  • 1Cancer Center, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong, China.

Cancer Drug Resistance (Alhambra, Calif.)
|October 15, 2024
PubMed

Insights

Head and neck cancer (HNC) drug resistance is a major challenge. Non-coding RNAs are key players, and new strategies like ferroptosis and AI offer hope for improved HNC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Head and neck cancer (HNC) is a significant global health concern, ranking as the sixth most common malignancy.
  • Current treatment outcomes for HNC are often limited by the development of drug resistance.
  • Non-coding RNAs have emerged as critical regulators in the mechanisms underlying HNC drug resistance.

Purpose of the Study:

  • To systematically review the current research on non-coding RNAs and their role in HNC drug resistance.
  • To explore novel therapeutic targets and strategies for overcoming HNC resistance.
  • To identify and discuss promising future research directions in this field.

Main Methods:

  • Systematic literature review of studies investigating non-coding RNAs in HNC drug resistance.
  • Analysis of emerging therapeutic modalities and their potential application in HNC.
  • Identification of key challenges and future research avenues.

Main Results:

  • Non-coding RNAs significantly influence the development of resistance to antitumor therapies in HNC.
  • Several novel therapeutic strategies, including ferroptosis, nanomedicine, exosomes, PROTACs, and AI, show promise for targeting non-coding RNAs.
  • Understanding the complex interplay between non-coding RNAs and drug resistance is crucial for therapeutic advancement.

Conclusions:

  • Targeting non-coding RNAs represents a promising avenue for overcoming drug resistance in head and neck cancer.
  • Future research integrating ferroptosis, nanomedicine, exosomes, PROTACs, and artificial intelligence holds potential for novel HNC treatment strategies.
  • Further investigation is needed to fully elucidate the role of non-coding RNAs and develop effective clinical applications for HNC resistance.
Keywords:
Head and neck cancercircular RNAdrug resistancelong non-coding RNAmicroRNAnon-coding RNA

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.5K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

9.7K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K